Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| 2501444 | Other Identifier | VMK |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| The Novo Nordic Foundation | OTHER |
Not provided
Not provided
Not provided
Not provided
This is a pragmatic, two-group, cluster randomized trial designed to compare strategies for the Anti Tachycardia Pacing (ATP)-setting in the ventricular tachyarrhythmias (VT) zone when implanting a new implantable cardioverter defibrillator (ICD) in patients with heart disease in hospitals in Denmark.
The strategies are: "Burst" or "Ramp" after 1. ATP (which is always burst) in VT zone. VT zone is defined between 180-249 (up to 269 in special cases) heartbeats per minute.
The ICD will give either:
Burst: The ICD is programmed to give ATP with 4 bursts. Or Ramp: The ICD is programmed to give ATP with 1 burst and 3 ramps.
The participating hospitals will be assigned to one of two intervention strategies for periods of 4-months. The given intervention will follow the patient/ICD throughout the life time of the ICD, but with the possibility to reprogram at any time (intention to treat).
It is calculated that the study needs a total of 398 events (second to fourth ATP), which is estimated to require 3980 implanted ICDs. The participants will be followed until the end of the ICD life, which is estimated to be around 10 years.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Burst | Experimental |
| |
| Ramp | Experimental |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Burst | Other | ATP with 4 burst |
| |
| Ramp |
| Measure | Description | Time Frame |
|---|---|---|
| Arrhythmia cessation | The ability of the given ATP protocol to stop the ventricular arrhythmia | The lifetime of the ICD, estimated 10 years |
| Measure | Description | Time Frame |
|---|---|---|
| Defibrillation | Arrhythmia accelerates resulting in defibrillation/shock therapy | The lifetime of the ICD, estimated 10 years |
Not provided
Inclusion Criteria:
- ICD implantation for primary or secondary prophylactic indication
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Bo G Winkel, MD, PhD | Contact | +4535459759 | bo.winkel@regionh.dk |
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| The Heart Center, Rigshospitalet | Copenhagen | Dr. | 2100 | Denmark |
The data are considered sensitive personal data.
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D006331 | Heart Diseases |
| D001145 | Arrhythmias, Cardiac |
| D017180 | Tachycardia, Ventricular |
| D006333 | Heart Failure |
| ID | Term |
|---|---|
| D002318 | Cardiovascular Diseases |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D013610 | Tachycardia |
Not provided
Not provided
| ID | Term |
|---|---|
| D001107 | Architectural Accessibility |
| ID | Term |
|---|---|
| D005160 | Facility Design and Construction |
| D001108 | Architecture |
| D013676 | Technology, Industry, and Agriculture |
Not provided
Not provided
The study is a pragmatic, two-group, cluster randomized trial. With clusters of time periods of 4-month duration at all sites.
Not provided
Not provided
Not provided
Not provided
| Other |
ATP with 1 Burst + 3 Ramp |
|
| D000075224 | Cardiac Conduction System Disease |